RENNES: A man who was left brain-dead after suffering serious side-effects during a drugs trial in France died on Sunday, according to the hospital which had been treating him. Five other volunteers hospitalised a week ago when the drugs trial went wrong were “in a stable condition”, the hospital in the western city of Rennes said in a statement. The private laboratory Biotrial was testing a new pain and mood disorder medication for Portuguese pharmaceutical company Bial on humans for the first time, in what is known as a Phase I trial, to test the drug’s safety. A total of 108 volunteers took part in the trial, 90 of whom received the drug at varying doses while the rest were given placebos. The six men who were hospitalised were the group which received the highest dose.